Dr Reddy’s Laboratories is “well set for growth” by focusing on six key spaces, according to the Indian firm’s chief operating officer and global head of generics and pharmaceutical services and active ingredients (PSAI), Erez Israeli.
Speaking at the 37th Annual J.P. Morgan Healthcare Conference held in San Francisco, California, Israeli said Dr Reddy’s plans primarily...




